Skip to main content

The independent source for health policy research, polling, and news.

Subscribe Follow Us Donate
  • Trump 2.0

    Trump 2.0

    • Agency Watch
    • State Watch
    • Rural Health Payout
  • Public Health

    Public Health

    • Vaccines
    • CDC & Disease
    • Environmental Health
    All Public Health
  • Audio Reports

    Audio Reports

    • What the Health?
    • Health Care Helpline
    • KFF Health News Minute
    • An Arm and a Leg
    • Health Hub
    • HealthQ
    • Silence in Sikeston
    • Epidemic
    All Audio
  • Special Reports

    Special Reports

    • Bill Of The Month
    • The Body Shops
    • Broken Rehab
    • Deadly Denials
    • Priced Out
    • Dead Zone
    • Diagnosis: Debt
    • Overpayment Outrage
    • Opioid Settlement Tracking
    All Special Reports
  • More Topics

    More Topics

    • Elections
    • Health Care Costs
    • Insurance
    • Prescription Drugs
    • Health Industry
    • Immigration
    • Reproductive Health
    • Technology
    • Rural Health
    • Race and Health
    • Aging
    • Mental Health
    • Affordable Care Act
    • Medicare
    • Medicaid
    • Children’s Health

  • Vaccine Policy
  • ‘Beyond Medical Necessity’ Hospital Stays
  • Trump’s Eli Lilly Stock Purchases
  • Changes Coming to ACA Exchanges
  • Texas ‘Detransition Clinic’

WHAT'S NEW

  • Vaccine Policy
  • 'Beyond Medical Necessity' Hospital Stays
  • Trump's Eli Lilly Stock Purchases
  • Changes Coming to ACA Exchanges
  • Texas 'Detransition Clinic'

Morning Briefing

Summaries of health policy coverage from major news organizations

  • Email

Wednesday, Nov 18 2020

Full Issue

China's Vaccine Appears Safe, But It Produces Lower Levels Of Antibodies

Other global news is from Russia, Sweden, Italy, Belgium and the Netherlands.

The Washington Post: China's Sinovac Reports Mixed Findings In Early Clinical Trials 

Sinovac Biotech, one of China's coronavirus vaccine front-runners, published mixed findings from its two first clinical trials Tuesday, raising the stakes in Indonesia, which has already declared plans to roll out Sinovac's vaccine. While the vaccine appeared to be safe in these early clinical trials, the company reported that it generated lower levels of protective antibodies in the bloodstream compared with those arising in recovered coronavirus patients. In comparison, Moderna and Pfizer had reported antibody levels on par with or higher than those produced in recovered coronavirus patients. (Dou, 11/18)

AP: Putin Touts Russian Virus Vaccines At BRICS Summit

Russian President Vladimir Putin told BRICS leaders Tuesday that coronavirus vaccines developed in Russia “work effectively and safely” and urged the group of emerging economy nations to “join forces” for the mass production of the shots. Putin’s remarks come after early results of large studies of several experimental COVID-19 vaccines, including a Russian one, were announced. The BRICS grouping is made up of Brazil, Russia, India, China and South Africa. (Litvinova, 11/17)

The Washington Post: Has Sweden's Coronavirus Strategy Failed? 

Even Sweden appears to be abandoning the Swedish model. On Monday, the country’s authorities banned gatherings of more than eight people as they grappled with the second coronavirus wave surging through much of Europe. The new restrictions followed other protocols coming into effect this week, including protective measures around nursing homes and bans on alcohol sales at restaurants and bars after 10 p.m. (Tharoor, 11/18)

Politico: Rome Heads Toward Coronavirus Disaster

It was only recently that Italy’s coronavirus response was being held up as an example by newspapers around the world. Now it looks like the country is shuffling towards a slow-motion disaster. In Naples, Italy’s third-biggest city and the heart of the mezzogiorno, the country’s south, ambulances carrying COVID-19 patients queued up outside overflowing hospitals. Images of an elderly man who died in a hospital bathroom and was reportedly left on the floor for over half an hour also prompted outrage. (Martuscelli, 11/14)

The Washington Post: Nursing Home Covid Cases Propel Belgium To One Of The World's Worst Death Rates. Again. 

One Belgian doctor described nursing homes in his country as a scene of “carnage” in the first wave of the coronavirus pandemic, with fatalities inside the institutions pushing Belgium to a worst-in-the-world death toll. Afterward, policymakers vowed to fortify the care homes to protect against a potential new surge. Yet deep into a second wave, the virus is racing through nursing homes once more, and advocates say some of the same broad mistakes are cementing Belgium’s status as a country where reported coronavirus deaths per capita are off the charts. (Birnbaum, 11/17)

AP: Dutch Virus Restrictions To Be Eased Amid Falling Infections

Dutch Prime Minister Mark Rutte eased his country’s coronavirus measures Tuesday amid falling infection rates, allowing public venues including cinemas, museums and libraries to reopen — with limitations on how many people can visit — after a two-week closure. The venues, which also include zoos and swimming pools, will be allowed to reopen at midnight Wednesday, Rutte said. (11/17)

This is part of the Morning Briefing, a summary of health policy coverage from major news organizations. Sign up for an email subscription.
Newsletter icon

Sign Up For Our Newsletter

Stay informed by signing up for the Morning Briefing and other emails:

Recent Morning Briefings

  • Today, May 18
  • Friday, May 15
  • Thursday, May 14
  • Wednesday, May 13
  • Tuesday, May 12
  • Monday, May 11
More Morning Briefings
RSS Feeds
  • Podcasts
  • Special Reports
  • Morning Briefing
  • About Us
  • Donate
  • Staff
  • Republish Our Content
  • Contact Us

Follow Us

  • Instagram
  • YouTube
  • LinkedIn
  • Facebook
  • X
  • Bluesky
  • TikTok
  • RSS

Sign up for emails

Join our email list for regular updates based on your personal preferences.

Sign up
  • Editorial Policy
  • Privacy Policy

© 2026 KFF